673 related articles for article (PubMed ID: 26002567)
1. Characterization of gelation process and drug release profile of thermosensitive liquid lecithin/poloxamer 407 based gels as carriers for percutaneous delivery of ibuprofen.
Djekic L; Krajisnik D; Martinovic M; Djordjevic D; Primorac M
Int J Pharm; 2015 Jul; 490(1-2):180-9. PubMed ID: 26002567
[TBL] [Abstract][Full Text] [Related]
2. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.
Jhawat V; Gupta S; Saini V
Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro evaluation of a pluronic lecithin organogel containing ricinoleic acid for transdermal delivery.
Boddu SH; Bonam SP; Wei Y; Alexander K
Int J Pharm Compd; 2014; 18(3):256-61. PubMed ID: 25306775
[TBL] [Abstract][Full Text] [Related]
4. The clinical efficacy of cosmeceutical application of liquid crystalline nanostructured dispersions of alpha lipoic acid as anti-wrinkle.
Sherif S; Bendas ER; Badawy S
Eur J Pharm Biopharm; 2014 Feb; 86(2):251-9. PubMed ID: 24056055
[TBL] [Abstract][Full Text] [Related]
5. Design of Block Copolymer Costabilized Nonionic Microemulsions and Their In Vitro and In Vivo Assessment as Carriers for Sustained Regional Delivery of Ibuprofen via Topical Administration.
Djekic L; Martinovic M; Stepanović-Petrović R; Tomić M; Micov A; Primorac M
J Pharm Sci; 2015 Aug; 104(8):2501-12. PubMed ID: 26045240
[TBL] [Abstract][Full Text] [Related]
6. Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.
Kojarunchitt T; Baldursdottir S; Dong YD; Boyd BJ; Rades T; Hook S
Eur J Pharm Biopharm; 2015 Jan; 89():74-81. PubMed ID: 25481034
[TBL] [Abstract][Full Text] [Related]
7. Thermosensitive Poloxamer 407/Poly(Acrylic Acid) Hydrogels with Potential Application as Injectable Drug Delivery System.
Boonlai W; Tantishaiyakul V; Hirun N; Sangfai T; Suknuntha K
AAPS PharmSciTech; 2018 Jul; 19(5):2103-2117. PubMed ID: 29696613
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of a ricinoleic acid poloxamer gel system for transdermal eyelid delivery.
Boddu SH; Bonam SP; Jung R
Drug Dev Ind Pharm; 2015 Apr; 41(4):605-12. PubMed ID: 24517574
[TBL] [Abstract][Full Text] [Related]
9. Pluronic lecithin organogel as a topical drug delivery system.
Pandey M; Belgamwar V; Gattani S; Surana S; Tekade A
Drug Deliv; 2010 Jan; 17(1):38-47. PubMed ID: 22747074
[TBL] [Abstract][Full Text] [Related]
10. Development and characterisation of modified poloxamer 407 thermoresponsive depot systems containing cubosomes.
Kojarunchitt T; Hook S; Rizwan S; Rades T; Baldursdottir S
Int J Pharm; 2011 Apr; 408(1-2):20-6. PubMed ID: 21272624
[TBL] [Abstract][Full Text] [Related]
11. Influence of lecithin on some physical chemical properties of poloxamer gels: rheological, microscopic and in vitro permeation studies.
Bentley MV; Marchetti JM; Ricardo N; Ali-Abi Z; Collett JH
Int J Pharm; 1999 Dec; 193(1):49-55. PubMed ID: 10581421
[TBL] [Abstract][Full Text] [Related]
12. Propolis organogel as a novel topical delivery system for treating wounds.
Balata G; El Nahas HM; Radwan S
Drug Deliv; 2014 Feb; 21(1):55-61. PubMed ID: 24295500
[TBL] [Abstract][Full Text] [Related]
13. Investigation of surfactant/cosurfactant synergism impact on ibuprofen solubilization capacity and drug release characteristics of nonionic microemulsions.
Djekic L; Primorac M; Filipic S; Agbaba D
Int J Pharm; 2012 Aug; 433(1-2):25-33. PubMed ID: 22579578
[TBL] [Abstract][Full Text] [Related]
14. Influence of oleic acid on the rheology and in vitro release of lumiracoxib from poloxamer gels.
Moreira TS; de Sousa VP; Pierre MB
J Pharm Pharm Sci; 2010; 13(2):286-302. PubMed ID: 20816013
[TBL] [Abstract][Full Text] [Related]
15. Formulation, functional evaluation and ex vivo performance of thermoresponsive soluble gels - A platform for therapeutic delivery to mucosal sinus tissue.
Pandey P; Cabot PJ; Wallwork B; Panizza BJ; Parekh HS
Eur J Pharm Sci; 2017 Jan; 96():499-507. PubMed ID: 27771516
[TBL] [Abstract][Full Text] [Related]
16. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
[TBL] [Abstract][Full Text] [Related]
17. Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution.
Wei Y; Li C; Zhu Q; Zhang X; Guan J; Mao S
Int J Pharm; 2020 Mar; 578():119184. PubMed ID: 32112932
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of thermosensitive poloxamer 407 gel systems for the sustained release of estradiol in a fish model.
Cespi M; Bonacucina G; Pucciarelli S; Cocci P; Perinelli DR; Casettari L; Illum L; Palmieri GF; Palermo FA; Mosconi G
Eur J Pharm Biopharm; 2014 Nov; 88(3):954-61. PubMed ID: 25194925
[TBL] [Abstract][Full Text] [Related]
19. Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide.
Yuan Y; Cui Y; Zhang L; Zhu HP; Guo YS; Zhong B; Hu X; Zhang L; Wang XH; Chen L
Int J Pharm; 2012 Jul; 430(1-2):114-9. PubMed ID: 22503953
[TBL] [Abstract][Full Text] [Related]
20. Self-Assembling Organogels Based on Pluronic and Lecithin for Sustained Release of Etodolac: In Vitro and In Vivo Correlation.
Mohammed AM; Faisal W; Saleh KI; Osman SK
Curr Drug Deliv; 2017; 14(7):926-934. PubMed ID: 27593184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
